SCOPE 365 Connect

SCOPE 365 is joined by Trialbee for a conversation about where AI is delivering practical value in clinical trial recruitment and what it takes to preserve patient choice, trust, and human connection. Together, we’ll explore how recruitment teams can put AI to work while giving patients the information and support they need to make their own decisions.

The Discussion

AI is creating opportunities across patient identification, outreach, prescreening, referral, and enrollment. Making those tools useful means understanding how they fit into daily site workflows, how patients want to communicate, and what sponsors can learn from recruitment activity across their studies.

This SCOPE 365 Connect brings those questions into an open, practical discussion. We’ll consider where AI can make recruitment easier, what teams need to rethink, and where a conversation with a person makes the difference.

What We’ll Explore

• Patient choice: How can recruitment teams accommodate different preferences for receiving information, asking questions, and getting support?
• Practical tools for sites: Where can AI help sites identify and reach potential participants, manage follow-up, and strengthen patient connections?
• Recruitment insights for sponsors: What can teams learn from their recruitment data across trials, indications, and countries?
• Human connection: Where are personal interaction and human judgment essential as AI becomes part of recruitment?

Moderator
Matt Walz
CEO, Trialbee

How to Participate

SCOPE 365 Connect sessions are built around attendee participation. Bring a question, share a challenge from your work, or offer your perspective on what is working in recruitment today.

Whether you work at a site, sponsor, CRO, or technology provider, your experience can help move the discussion forward. Join us ahead of SCOPE Europe, October 13–14 in Barcelona, to start a conversation we can continue in person.

Join the Conversation

Register for this free October 7 session through the LinkedIn event page. Bring your questions for Matt Walz and fellow participants.